These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23015200)

  • 1. Prevalence of Iron Deficiency and Iron Administration in Left Ventricular Assist Device and Heart Transplantation Patients.
    Veenis JF; Radhoe SP; Roest S; Caliskan K; Constantinescu AA; Manintveld OC; Brugts JJ
    ASAIO J; 2022 Jul; 68(7):899-906. PubMed ID: 34643575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pulmonary System: A Different Sort of End Organ for Left Ventricular Assist Device Therapy.
    Shirafkan A; Gidea CG; Stein LH
    Am J Cardiol; 2023 Aug; 201():372-373. PubMed ID: 37407388
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of atrial flow regulator implantation in pulmonary arterial hypertension patients with severe heart failure despite maximal medical therapy.
    Kopeć G; Araszkiewicz A; Magoń W; Stępniewski J; Sławek-Szmyt S; Janus M; Skoczylas I; Gąsior Z; Wilczek Ł; Komar M; Gackowski A; Sabiniewicz A
    Kardiol Pol; 2024; 82(1):75-78. PubMed ID: 37537913
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.
    Jensen CW; Goldstone AB; Woo YJ
    Curr Heart Fail Rep; 2016 Jun; 13(3):140-50. PubMed ID: 27241336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biventricular failure with low pulmonary vascular resistance was managed by left ventricular assist device alone without right-sided mechanical support.
    Imamura T; Kinugawa K; Nitta D; Hatano M; Kinoshita O; Nawata K; Ono M
    J Artif Organs; 2015 Sep; 18(3):272-5. PubMed ID: 25773932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The practical role of echocardiography in selection, implantation, and management of patients requiring LVAD therapy.
    Todaro MC; Khandheria BK; Paterick TE; Umland MM; Thohan V
    Curr Cardiol Rep; 2014 Apr; 16(4):468. PubMed ID: 24585110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Journal of Artificial Organs 2013: the year in review : Journal of Artificial Organs Editorial Committee.
    Sawa Y; Tatsumi E; Tsukiya T; Matsuda K; Fukunaga K; Kishida A; Masuzawa T; Matsumiya G; Myoui A; Nishimura M; Nishimura T; Nishinaka T; Okamoto E; Tokunaga S; Tomo T; Yagi Y; Yamaoka T;
    J Artif Organs; 2014 Mar; 17(1):1-8. PubMed ID: 24569884
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute pulmonary vasoreactivity test with sildenafil or nitric monoxide before left ventricular assist device implantation.
    Imamura T; Kinugawa K; Hatano M; Kato N; Minatsuki S; Muraoka H; Inaba T; Maki H; Kimura M; Kinoshita O; Shiga T; Yao A; Kyo S; Ono M; Komuro I
    J Artif Organs; 2013 Sep; 16(3):389-92. PubMed ID: 23559349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.
    Mikus E; Stepanenko A; Krabatsch T; Loforte A; Dandel M; Lehmkuhl HB; Hetzer R; Potapov EV
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):971-7. PubMed ID: 21354812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label use of pulmonary vasodilators after left ventricular assist device implantation: Calling in the evidence.
    Papathanasiou M; Ruhparwar A; Kamler M; Rassaf T; Luedike P
    Pharmacol Ther; 2020 Oct; 214():107619. PubMed ID: 32599009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device.
    Imamura T; Kinugawa K; Hatano M; Kato N; Minatsuki S; Muraoka H; Inaba T; Maki H; Shiga T; Yao A; Kyo S; Ono M; Nagai R
    J Artif Organs; 2013 Mar; 16(1):101-4. PubMed ID: 23015200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of secondary pulmonary hypertension with bosentan after left ventricular assist device implantation.
    LaRue SJ; Garcia-Cortes R; Nassif ME; Vader JM; Ray S; Ravichandran A; Rasalingham R; Silvestry SC; Ewald GA; Wang IW; Schilling JD
    Cardiovasc Ther; 2015 Apr; 33(2):50-5. PubMed ID: 25759010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience with bosentan therapy in patients considered ineligible for heart transplantation because of severe pulmonary hypertension.
    Perez-Villa F; Cuppoletti A; Rossel V; Vallejos I; Roig E
    Clin Transplant; 2006; 20(2):239-44. PubMed ID: 16640533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bosentan on pulmonary hypertension secondary to systolic heart failure.
    Padeletti M; Caputo M; Zacà V; Tsioulpas C; Bernazzali S; Mondillo S; Maccherini M; Jelic S
    Pharmacology; 2013; 92(5-6):281-5. PubMed ID: 24296902
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.